Genenta Science S.p.A. (ADR) share price logo

Genenta Science S.p.A. (ADR)

NASDAQ: GNTA

Small Cap

$1.81

+0.08

(+4.62%)

as on

Genenta Science S.p.A. (ADR) Stock Performance

as on June 27, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $1.69
    $1.80
    downward going graph

    6.63%

    Downside

    -0.55%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.55
    $10.00
    downward going graph

    69.61%

    Downside

    452.49%

    Upside

    downward going graph

Genenta Science S.p.A. (ADR) share price movements today

Previous Close
$1.73
Open
$1.70
Volume
595.0K
Day's Low - High
$1.69 - $1.80
52 Week Low - High
$0.55 - $10.00

Genenta Science S.p.A. (ADR) Historical Returns

1 Month Return
+ 189.59 %
3 Month Return
+ 108.94 %
1 Year Return
-43.19 %
3 Year Return
-67.78 %
5 Year Return
0 %

Genenta Science S.p.A. (ADR) Stock Fundamentals & Key Indicators

Check Genenta Science S.p.A. (ADR) market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$41.0M

EPS (TTM)

-0.46

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-6.6M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-38.03%

Genenta Science S.p.A. (ADR) vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Genenta Science S.p.A. (ADR) with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$41.0MNANA0.00%NA
BUY$39.3B67.15%74.0712.55%NA
BUY$120.6B147.08%28.1735.51%NA
BUY$65.4B12.64%15.2229.65%0.58%

Stock Returns calculator for Genenta Science S.p.A. (ADR) Stock including INR - Dollar returns

The Genenta Science S.p.A. (ADR) stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Genenta Science S.p.A. (ADR) investment value today

Current value as on today

₹65,514

Returns

-₹34,486

(-34.49%)

Returns from Genenta Science S.p.A. (ADR) Stock

-₹40,461 (-40.46%)

Dollar Impact

₹5,975 (+5.97%)

Analyst Recommendation on Genenta Science S.p.A. (ADR) Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Genenta Science S.p.A. (ADR). Average target price of $6.98

Genenta Science S.p.A. (ADR) Share Price Target

Get share price movements and forecasts by analysts on Genenta Science S.p.A. (ADR).

What analysts predicted

74.07%UPSIDE

Target Price

$6.98

Current Price

$1.81

Analyzed by

8 Analysts

Target

$6.98

Genenta Science S.p.A. (ADR) target price $6.98, a slight upside of 74.07% compared to current price of $1.81. According to 8 analysts rating.

Indian Investors' Interest in Genenta Science S.p.A. (ADR) Stock

Investment in Genenta Science S.p.A. (ADR) Shares on INDmoney has grown by 1081.81% in the last 30 days, indicating increased investment activity.

Time period: to

Change:1081.81% versus previous 30 day period

Search interest for Genenta Science S.p.A. (ADR) Stock has increased by 1661% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:1661% versus previous 30 day period

Genenta Science S.p.A. (ADR) Quarterly Profit & Loss

All numbers in Millions USD

Total Revenue
Gross Profit
Operating Income
EBITDA
Interest Expense
Depreciation
Income Before Tax
Income Tax Expense
Net Income
Net Profit Margin

Genenta Science S.p.A. (ADR) Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
Gross Profit
-
0
0
0
0
0
0
Operating Income
-4
-5
-5
-10
-11
-10
-6
EBITDA
-4
-5
-5
-8
-11
-9
-5
Interest Expense
0
0
0
2
-
-
0
Depreciation
-
0
0
0
0
0
0
Income Before Tax
-4
-5
-5
-8
-11
-9
-6
Income Tax Expense
0
0
0
-4
0
-
-
Net Income
-5
-6
-6
-8
-12
-9
-6
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Genenta Science S.p.A. (ADR) Quarterly Cash Flow

All numbers in Millions USD

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Jun 2024
Dec 2024
Sep 2025
Mar 2026
Net Income
-3
-6
-6
0
0
0
-8
-4
-2
Operating Cash Flow
-2
-4
-7
0
0
0
0
-6
-1
Investing Cash Flow
0
0
-9
-
0
0
0
-4
-10
Financing Cash Flow
-
-
-
-
-
0
0
11
12
Change in Cash
-8
-2
-17
0
0
0
4
1
0

Genenta Science S.p.A. (ADR) Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-5
-5
-8
-11
-8
-6
Operating Cash Flow
-6
-6
-7
-11
-6
-6
Investing Cash Flow
0
0
0
-14
6
-14
Financing Cash Flow
1
28
-
0
0
22
Change in Cash
-4
21
-7
-26
0
0

Global Institutional Holdings in Genenta Science S.p.A. (ADR)

Funds
Holdings
UBS Group AG
0.01%
Ghisallo Capital Management LLC
0%
Citadel Advisors Llc
0%
NORGES BANK
0.96%
AlTi Global Inc
0.85%

Insights on Genenta Science S.p.A. (ADR)

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, GNTA stock has moved up by 102.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Genenta Science S.p.A. American Depositary Shares has experienced a drawdown of -69.2%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 59.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 21.5% return, outperforming this stock by 63.1%

About Genenta Science S.p.A. (ADR)

Genenta Science S.p.A., a clinical-stage biotechnology company, develops hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company offers Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter. It is developing Temferon for use in the treatment of other solid tumor indications. In addition, the company develops biologic platform to deliver immunomodulatory molecules directly to the tumor by infiltrating monocytes/macrophages. Genenta Science S.p.A. was incorporated in 2014 and is headquartered in Milan, Italy.
OrganisationGenenta Science S.p.A. (ADR)
HeadquartersVia Olgettina No. 58, Milan, MI, Italy, 20132
IndustryBiotechnology
CEOMr. Pierluigi Paracchi
E-voting on sharesClick here to vote

Key Management of Genenta Science S.p.A. (ADR)

Name

Title

Ms. Barbara Regonini

Director of Finance

Mr. Pierluigi Paracchi

Co-Founder, Chairman, CEO & GM

Dr. Luigi Naldini M.D., Ph.D.

Co-Founder & Chairman of Scientific Advisory Board

Dr. Bernard Rudolph Gentner M.D., Ph.D.

CO-Founder & Scientific Advisory Board Member

Mr. Richard B. Slansky

Principal Financial & Accounting Officer

Mr. Gianfranco De Nigris

Vice President Corporate Development

Dr. Francesco Galimi M.D., Ph.D.

Chief Medical Officer, Head of Development & Director

Dr. Stefania Mazzoleni Ph.D.

Director of Program Development

FAQs

What is Genenta Science S.p.A. (ADR) share price today?

Genenta Science S.p.A. (ADR) share price today is $1.81 as on at the close of the market. Genenta Science S.p.A. (ADR) share today touched a day high of $1.8 and a low of $1.69.

What is the 52 week high and 52 week low for Genenta Science S.p.A. (ADR) share?

Genenta Science S.p.A. (ADR) share touched a 52 week high of $10 on and a 52 week low of $0.55 on . Genenta Science S.p.A. (ADR) stock price today i.e. is closed at $1.81,which is 81.90% down from its 52 week high and 229.09% up from its 52 week low.

What is Genenta Science S.p.A. (ADR)'s market capitalisation today?

Genenta Science S.p.A. (ADR) market capitalisation is $0.00T as on .

How to invest in Genenta Science S.p.A. (ADR) Stock (GNTA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Genenta Science S.p.A. (ADR) on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Genenta Science S.p.A. (ADR) Shares that will get you 0.8287 shares as per Genenta Science S.p.A. (ADR) share price of $1.81 per share as on June 27, 2026 at 8:46 am IST.

What is the minimum amount required to buy Genenta Science S.p.A. (ADR) Stock (GNTA) from India?

Indian investors can start investing in Genenta Science S.p.A. (ADR) (GNTA) shares with as little as ₹94.3 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹943.00 in Genenta Science S.p.A. (ADR) stock (as per the Rupee-Dollar exchange rate as on ). Based on Genenta Science S.p.A. (ADR) share’s latest price of $1.81 as on June 27, 2026 at 8:46 am IST, you will get 5.5249 shares of Genenta Science S.p.A. (ADR). Learn more about fractional shares .